Literature DB >> 24061295

Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.

Gyri Veiby1, Bernt A Engelsen, Nils Erik Gilhus.   

Abstract

IMPORTANCE: Exposure to antiepileptic drugs during pregnancy is associated with adverse effects on psychomotor development.
OBJECTIVES: To determine whether signs of impaired development appear already during the first months of life in children exposed prenatally to antiepileptic drugs, and to explore potential adverse effects of antiepileptic drug exposure through breastfeeding. DESIGN, SETTING, AND PARTICIPANTS: Mothers at 13 to 17 weeks of pregnancy were recruited in the population-based, prospective Norwegian Mother and Child Cohort Study from 1999 to 2009. The mothers reported on their child's motor and social skills, language, and behavior using items from standardized screening tools at 6 months (n = 78,744), 18 months (n = 61,351), and 36 months (n = 44,147) of age. The mothers also provided detailed information on breastfeeding during the first year. MAIN OUTCOMES AND MEASURES The risk of adverse development in children according to maternal or paternal epilepsy was estimated as the odds ratio with corresponding 95% confidence interval, adjusted for maternal age, parity, education, smoking, breastfeeding, depression/anxiety, folate supplementation, and congenital malformation in the child.
RESULTS: At age 6 months, infants of mothers using antiepileptic drugs (n = 223) had a higher risk of impaired fine motor skills compared with the reference group (11.5% vs 4.8%, respectively; odds ratio = 2.1; 95% CI, 1.3-3.2). Use of multiple antiepileptic drugs compared with the reference group was associated with adverse outcome for both fine motor skills (25.0% vs 4.8%, respectively; odds ratio = 4.3; 95% CI, 2.0-9.1) and social skills (22.5% vs 10.2%, respectively; odds ratio = 2.6; 95% CI, 1.2-5.5). Continuous breastfeeding in children of women using antiepileptic drugs was associated with less impaired development at ages 6 and 18 months compared with those with no breastfeeding or breastfeeding for less than 6 months. At 36 months, prenatal antiepileptic drug exposure was associated with adverse development regardless of breastfeeding status during the first year. Children of women with epilepsy who did not use antiepileptic drugs and children of fathers with epilepsy had normal development at 6 months. CONCLUSIONS AND RELEVANCE: Prenatal exposure to antiepileptic drugs was associated with impaired fine motor skills already at age 6 months, especially when the child was exposed to multiple drugs. There were no harmful effects of breastfeeding. Women with epilepsy should be encouraged to breastfeed their children irrespective of antiepileptic drug treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24061295     DOI: 10.1001/jamaneurol.2013.4290

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  35 in total

1.  Epilepsy: Effects of exposure to antiepileptic drugs during development.

Authors:  Frank Vajda
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

Review 2.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

3.  Breast is still best: no harmful effects of breastfeeding in women taking antiepileptic drugs.

Authors:  Elizabeth M Powell
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

Review 4.  Management of epilepsy during pregnancy: an update.

Authors:  Sima I Patel; Page B Pennell
Journal:  Ther Adv Neurol Disord       Date:  2015-12-27       Impact factor: 6.570

5.  Antiepileptic Medications and Breastfeeding: Better News Than Expected?

Authors:  Sheryl Haunt
Journal:  Epilepsy Curr       Date:  2016 Mar-Apr       Impact factor: 7.500

6.  Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.

Authors:  Gyri Veiby; Anne Kjersti Daltveit; Bernt A Engelsen; Nils Erik Gilhus
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

Review 7.  Practice Update: Review of Anticonvulsant Therapy.

Authors:  Derek J Chong; Andrew M Lerman
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

8.  Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  JAMA Pediatr       Date:  2014-08       Impact factor: 16.193

Review 9.  [Epilepsy and Pregnancy].

Authors:  K Menzler; S Fuest; I Immisch; S Knake
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

Review 10.  An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  J Pediatr Genet       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.